Merrimack Pharmaceuticals (MACK)
Add to Watchlists Create an Alert
5.11
-0.16 -3.04%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Merrimack Pharmaceuticals Cash from Investing Quarterly:
-15.37M for Dec. 31, 2012Merrimack Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -15.37M |
| Sept. 30, 2012 | 14.97M |
| June 30, 2012 | -74.39M |
| March 31, 2012 | -0.426M |
| Dec. 31, 2011 | -1.287M |
| Sept. 30, 2011 | -0.628M |
| June 30, 2011 | -1.271M |
| March 31, 2011 | -0.561M |
| Dec. 31, 2010 | -0.503M |
| Sept. 30, 2010 | -2.119M |
| June 30, 2010 | -1.903M |
| March 31, 2010 | -0.375M |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
MACK Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Threshold Pharmaceuticals | -24.33M |
| Immunogen | -0.307M |
| Achillion Pharmaceuticals | -99.19M |
MACK Cash from Investing Quarterly Rankings
| Overall |
63rd percentile 2912 of 8006 |
| Sector |
38th percentile 419 of 686 in Healthcare |
| Industry |
31st percentile 171 of 248 in Biotechnology |
MACK Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -74.39M | Jun 2012 |
| Maximum | 14.97M | Sep 2012 |
| Average | -6.989M |
